News

Enzalutamide Prolongs Prostate Cancer Survival After Chemotherapy Fails

Publish date: August 15, 2012

 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Click here to see a 2009 video of Dr. Scher discussing the rationale behind MDV3100 efficacy in advanced prostate cancer.

Pages

Recommended Reading

Surgery Didn't Cut Mortality from PSA-Detected Prostate Cancer
MDedge Family Medicine
Invasive SCC Rates Doubled in Last 20 Years
MDedge Family Medicine
FDA Approves mTOR Inhibitor Everolimus for Breast Cancer
MDedge Family Medicine
Cultivate 'Distress Tolerance' for Early-Stage Prostate Cancer
MDedge Family Medicine
Traffic-Related Toxins Linked to Childhood Kidney Cancer
MDedge Family Medicine
HPV DNA Test Predicts Cervical Cancer Risk for 18 Years
MDedge Family Medicine
Would Advanced Prostate Cancer Triple Without PSA Screening?
MDedge Family Medicine
Rare Brainstem Glioma Doesn't Stop Former Marine
MDedge Family Medicine
Labs Find Evidence of Cancer Stem Cells
MDedge Family Medicine
Pregnancy-Related Cancers: Rise Is Largely Unrelated to Delayed Childbearing
MDedge Family Medicine